EDP Sciences logo
Search
Menu
All issues Volume 43 / No 2 (March-April 2003) Reprod. Nutr. Dev., 43 2 (2003) 203-214 References
Free Access
Issue
Reprod. Nutr. Dev.
Volume 43, Number 2, March-April 2003
Page(s) 203 - 214
DOI https://doi.org/10.1051/rnd:2003017

References

  1. Gorbach SL, Knox TA, Roubenoff R. Interactions between nutrition and infection with human immunodeficiency virus. Nutr Rev 1993, 51: 226- 234.
  2. Sauerwein HP. Nutrition and AIDS. Clin Nutr 1993, 12: 64-68.
  3. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985, 42: 1255-1265.
  4. Chandra RK. 1990 McCollum Award lecture. Nutrition and immunity: lessons from the past and new insights into the future. Am J Clin Nutr 1991, 53: 1087-1101.
  5. Melchior JC, Chastang C, Gelas P, Carbonnel F, Zazzo JF, Boulier A, Cosnes J, Boulétreau P, Messing B. Efficacy of 2-month total parenteral nutrition in AIDS patients: A controlled randomized prospective trial. AIDS 1996, 10: 379-384.
  6. Burger B, Ollenschlager G, Schrappe M, Stute A, Fischer M, Wessel D, Schwenk A, Diehl V. Nutrition behavior of malnourished HIV-infected patients and intensified oral nutritional intervention. Nutrition 1993, 9: 43-44.
  7. Pichard C, Karsegard V, Kruseman M. Syndrome d'immunodéficience acquise. In: Leverve X, Cosnes J, Erny P, Hasselmann M (Eds), Traité de nutrition artificielle de l'adulte. Editions Mariette Guéna, 1998. p 853-869.
  8. Kotler DP, Tierney AR, Wang J, Pierson RN. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989, 50: 444-447.
  9. Macallan DC. Wasting in HIV infection and AIDS. J Nutr 1999, 129: 238S-242S.
  10. Macallan DC, McNurlan MA, Milne E, Calder AG, Garlick PJ, Griffin GE. Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr 1995, 61: 818-826.
  11. Selberg O, Süttmann U, Melzer A, Deicher H, Müller MJ, Henkel E, McMillan DC. Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss. Metabolism 1995, 44: 1159-1165.
  12. Laurichesse H, Tauveron I, Gourdon F, Cormerais L, Champredon C, Charrier S, Rochon C, Lamain S, Bayle G, Laveran H, Thieblot P, Beytout J, Grizard J. Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS. J Nutr 1998, 128: 1342-1348.
  13. Corcoran C, Grinspoon S. Treatments for wasting in patients with the acquired immunodeficiency syndrome. N Engl J Med 1999, 340: 1740- 1750.
  14. Mann M. Approved pharmacologic interventions for wasting: an overview and lessons learned. J Nutr 1999, 129: 303S-305S.
  15. Miller TL. Nutrition in paediatric human immunodeficiency virus infection. Proc Nutr Soc 2000, 59: 155-162.
  16. Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortl Wkly Rep 1993, 41: 1-19.
  17. Patureau Mirand P, Beaufrère B, Grizard J, Obled C, Arnal M. Les protéines et les acides aminés. In: Martin A (Ed), Les apports nutritionnels conseilléés à la population française, AFSSA-CNERNA. Tech. et Doc, Lavoisier, 2001. p 37-62.
  18. Rolland-Cachera MF, Brambilla P, Manzoni P, Akrout M, Sironi S, Delmaschio A, Chiumello G. Body composition assessed on the basis of arm circumference and triceps skinfold thickness: A new index validated in children by magnetic resonance imaging. Am J Clin Nutr 1997, 65: 1709- 1713.
  19. Bloxam DL, Warren WH. Error in the determination of tryptophan by the method of Denkla and Dewey. A revised procedure. Anal Biochem 1974, 60: 621-625.
  20. Hardin DS, LeBlanc A, Young D, Johnson P. Increased leucine turnover and insulin resistance in men with advanced HIV infection. J Investig Med 1999, 47: 405-413.
  21. Pannuti F, Martoni A, Camaggi CM. Medroxyprogesterone acetate high-dose in advanced breast cancer: Italian experience. German Italian Oncological Symposium, Milan. 1992.
  22. Simons JP, Schols AM, Hoefnagels JM, Westerterp KR, ten Velde GP, Wouters EF. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial. Cancer 1998, 82: 553-560.
  23. Saint-Marc T, Livrozet JM, Fournier F, Rambeaud B, Touraine JL. Intérêt de la médroxyprogesterone acétate dans le traitement de la cachexie du SIDA. Presse Med 1993, 22: 597.
  24. Scevola D, Zambelli A, Bottari G. Appetite stimulation and body weight gain with medroxyprogesterone acetate in AIDS anorexia and cachexia. Int J Drugs Ther 1991, 3: 77-83.
  25. Dardevet D, Sornet C, Balage M, Grizard J. Stimulation of in vitro rat muscle protein synthesis by leucine decreases with age. J Nutr 2000, 130: 2630-2635.
  26. Pichard C, Sudre P, Karsegard V, Yerly S, Slosman DO, Delley V, Perrin L, Hirschel B. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. AIDS 1998, 12: 53-63.
  27. Tauveron I, Charrier S, Champredon C, Bonnet Y, Berry C, Bayle G, Prugnaud J, Obled C, Grizard J, Thiéblot P. Response of leucine metabolism to hyperinsulinemia under amino acid replacement in experimental hyperthyroidism. Am J Physiol Endocrinol Metab 1995, 269: E499-E507.
  28. Rochon C, Tauveron I, Dejax C, Benoit P, Capitan P, Bayle G, Prugnaud J, Fabricio A, Berry C, Champredon C, Thieblot P, Grizard J. Response of leucine metabolism to hyperinsulinemia in hypothyroid patients before and after thyroxine replacement. J Clin Endocrinol Metab 2000, 85: 697-706.
  29. Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP, Flynn NM. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994, 121: 400-408.
  30. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS, Cone L, Brennan PJ, Weitzman SA. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994, 121: 393-399.
  31. Penzak SR, Chuck SK. Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. Scand J Infect Dis 2000, 32: 111-123.
  32. Mulligan K, Grunfeld C, Tai VW, Algren H, Pang MY, Chernoff DN, Lo JC, Schambelan M. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr 2000, 23: 35-43.
Abstract

Copyright INRA, EDP Sciences